Generalist · VC Firm

Golden Ventures

Toronto seed generalist whose US$40M Fund II turned an early Xanadu position (first cheque 2017) into roughly US$493M of XNDU stock at the May 2026 post-listing peak, per The Globe and Mail, still locked up until late September 2026.

Active Toronto, CanadaFounded 2011

Investment thesis

Seed-stage generalist, not a quantum specialist: US$364M AUM across seven vehicles (five core funds plus two opportunity funds), currently deploying Fund V (US$103M / CA$139M, final close December 2023).

Quantum exposure is concentrated in one outlier: Xanadu, backed since 2017, before the OMERS-led US$9M seed of 2018. Xanadu listed on Nasdaq and TSX (XNDU) in March 2026 via SPAC.

Per The Globe and Mail (May 2026), Golden's US$40M Fund II held Xanadu shares worth roughly US$493M at the post-listing peak, before the stock fell sharply on a May 2026 resale filing; the position remains locked up until late September 2026.

Second deep tech position, ProteinQure, has pivoted from quantum-assisted drug design to AI-designed peptide therapeutics (Phase I, PQ203); Golden followed on in its US$11M Series A (May 2025).

Anti-thesis

The patterns that trigger a fast no with this fund.

  1. No quantum thesis: a sector-agnostic seed fund whose quantum exposure is one legacy outlier; no new quantum-native investment since the 2017 Xanadu entry
  2. Golden has never publicly led a quantum round; the Xanadu seed was led by OMERS Ventures, and Golden is absent from the disclosed participant lists of the Series B (2021) and Series C (2022)
  3. Post-SPAC, Xanadu is a public-market position awaiting liquidity (lockup lifts late September 2026), not a signal of fresh private quantum appetite; the May 2026 resale filing wiped out roughly 60% of the paper gain
  4. US$500K-3M initial cheques against the capital intensity of quantum hardware: Golden cannot carry a photonics roadmap alone and depends entirely on downstream syndication
  5. ProteinQure, the only other deep tech position, has pivoted out of quantum into AI peptide design; pitching Golden on quantum today means pitching a fund with no active quantum reserve thesis

Notable quantum portfolio

Full portfolio
XanaduProteinQure

Frequent co-investors

  • OMERS Ventures
  • Real Ventures
  • Felicis
  • 8VC
  • iNovia
  • Heron Rock
  • Kensington Capital